CURETIS/ NL0011509294 /
2020-05-04 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.2900EUR | - | 1.04 mill. Turnover: - |
0.2855Bid Size: - | 0.2990Ask Size: - | 0.3080 | 0.2800 |
GlobeNewswire
2023-11-14
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-10-12
OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds
GlobeNewswire
2022-03-15
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2021 on ...
GlobeNewswire
2022-02-10
OpGen Announces Publication of Results from the Acuitas AMR Gene Panel Multicenter Clinical Trial in...
GlobeNewswire
2022-01-18
OpGen to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from Januar...
GlobeNewswire
2022-01-10
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2021 and Provides Business Update
GlobeNewswire
2021-12-14
OpGen subsidiary Ares Genetics announces the strategic expansion of ARESdb proprietary contents
GlobeNewswire
2021-11-30
OpGen Subsidiary Ares Genetics Announces Strategic Database Access Transaction
GlobeNewswire
2021-11-11
OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-11-04
OpGen Announces Special Meeting of Stockholders to Vote on Proposed Increase to Number of Authorized...
GlobeNewswire
2021-10-28
OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th a...
GlobeNewswire
2021-10-04
OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Thi...
GlobeNewswire
2021-09-15
OpGen Announces Data from Prospective Randomized Controlled Multicenter Clinical Study Using the Uny...
GlobeNewswire
2021-08-12
OpGen Reports Second Quarter 2021 Financial Results and Provides Business Update